Alzheimer's Disease

 Home Up Web Sites

 

 

 

Introduction

After reading an article in the San Diego Union-Tribune on February 21, 1996, I decided to confine my research paper and speech to Alzheimer's Disease.  It is a growing epidemic and could happen to any one of us as we reach our golden years.  I can only hope that my research will clarify the cause and effect that the disease has on its victims.

Here are a few of the questions that I will try to answer or clarify about Alzheimer's disease:

Who discovered Alzheimer's Disease?

What is Alzheimer's disease?

At what age does the disease present itself?

How accurate are predictions for Alzheimer's?

What is the cause of the disease?

What are the signs or symptoms?

What affect does it have on loved ones and friends?

Are there any medications on the market for Alzheimer's patients?

Conclusion

References

Additional Reading 

 

Top of page

Next

 

 

 

 

 

 

Who Discovered Alzheimer's Disease?

In 1906 a German neuropathologist by the name of Alois Alzheimer described this dreaded disease and found through his studies that approximately 2.5 to 4 million persons in the United States alone are afflicted each year.  About 17 to 20 million people around the world suffer from Alzheimer's and may be due to two bad copies of the inherited presenilin-1 (PS-1) gene (The U.S. Alzheimer's Disease Collaborative Group), London (Reuter)

Top of page

Next

 

 

 

 

 

What is Alzheimer's?

Alzheimer's can be defined as a progressive degenerative disease of the brain which increases with the advancement of age and is a leading cause of dementia, (Funk & Wagnall's Corporation).

We know very little about this disease.  There was a time when the average life expectancy of persons with the disease was between five and ten years, although due to the improvement in care and medical treatments their lives have been expanded to fifteen years or more.

Top of page

Next

 

 

 

 

 

 

At What Age Does it Show Up?

It has been found through studies that were published in "The Journal of the American Medical Association," on February 21, 1996, that Alzheimer's disease can be detected as early as 20 years of age (San Diego Union-Tribune).  The study was based on the autobiographies of 93 young women who were about to join an order of nuns.  All of these women had similar backgrounds, were born before 1917, and all were white.  The advantage of studying the nuns, was that they lived together in the same environment for 60 years, and had the same diet.  Therefore, this study does not address the questions of whether race, reproductive history, diet or environment can affect the risk of Alzheimer's disease.

Top of page

Next

 

 

 

 

 

 

Can Researchers Predict Who Will Have Alzheimer's?

The researchers were able to predict with 90 percent accuracy which ones would develop Alzheimer's disease when they were in their golden years.  Recent studies show that a small percentage of Alzheimer's cases may be inherited.  These women are now in their 80's and nearly one third of them are afflicted with the disease.  It was found that the women that wrote sentences that were grammatically complex and packed full of ideas when they were in their 20's remained sharp of mind.  The women that used sentences that were simple and lacked complex grammatical constructions were demented by the time they were in their 60's.  The research also showed that no matter how well educated the women were it was not a deterrent for Alzheimer's.

Top of page

Next

 

 

 

 

 

What Causes Alzheimer's?

The American Medical Association (Random House, Ó1987 &1989), stated that the underlying cause of Alzheimer's disease is not known, but studies have revealed the physical affects it has on the brain tissue:  the brain becomes shrunken from loss of nerve cells, and the nerve tracts become distorted as a result of deposition in the brain of the protein called amyloid.  There are also theories proposed, ranging from the effects of a chronic infection to those of toxic poisoning by a metal such as aluminum.  

Top of page

Next

 

 

 

 

 

 

What Are The Signs or Symptoms?

The symptoms and signs of the disease vary for each individual, although there are three broad stages:

bullet

The first stage is when the person notices his or her increased forgetfulness and may try to compensate by writing lists or asking for the help of others around them.  Because of this forgetfulness the person feels anxious and depressed.

bullet

The second phase is severe memory loss, especially of recent events.  The victim may remember things from their past when they were young, but are unable to remember people or events that took place the day before.  They become disoriented as to time or place, losing their way in familiar surroundings.  Their concentration declines, anxiety increases, mood changes are sudden and unpredictable, and personality changes soon become apparent.

bullet

The third stage is when the person becomes severely disoriented and confused, and may suffer from symptoms of psychosis, such hallucinations and paranoid delusions.  These symptoms are usually more severe at night.  These people show signs of nervous system disease, such as involuntary reflexes, such as shaking uncontrollably.  

Some of these afflicted people become demanding, unpleasant and sometimes violent.  Others become docile and somewhat helpless.  They neglect personal hygiene and may wander aimlessly.

Top of page

Next

 

 

 

 

 

What Medications Are Available?

Doctors can prescribe Cognex (tacrine hydrochloride)  for the afflicted individual to treat symptoms.  It is not a cure and eventually the disease will take precedence.  This disease can be diagnosed in one of two ways, by examination of the brain, either by brain biopsy or by a coroner after death of the afflicted person.  There are tests going on by American Biogenetic Sciences, Inc., that covers blood tests for Alzheimer's Disease.  In announcing the issuance and licensing of the patent, Alfred J. Roach, Chairman and CEO, stated that the Tau-Peptide Screening Test (tPST Ô) "strengthens our neurobiology program, and we look to form alliances with other companies in this field.  This is an example of how the ABS Global Scientific Network can be utilized to identify and develop more effective diagnostic and treatment products."  [Trinity College (Dublin, Ireland)].

There is also an eye test that researchers have been working on.  Huntington Potter, a neuroscientist at Harvard Medical School, who ingeniously followed up on an observation about people with Down Syndrome, a genetic disorder that causes mental retardation.  Potter knew that almost all Down patients who live long enough eventually develop brain lesions identical to those detected in autopsies of Alzheimer's suffers.  By scouring the scientific literature, he learned that people with Down Syndrome are very sensitive to tropicamide, the used to dilate the pupil of the eye.  Potter then approached Leonard Scinto, a neuroscientist now at Brigham and Women's Hospital in Boston, about the possibility of using the drug to spot Alzheimer's.

The past decade has seen remarkable developments in brain imaging.  Both magnetic resonance and radiotracer imaging methods have been demonstrated to have value in the diagnosis and monitoring of Alzheimer's disease.  Diagnostic accuracy in early cases is now at a level where the images can be clinically useful, but the goal is to raise the art to a level of probilistic quantitative interpretation, (Brigham and Women's Hospital, Harvard Medical School)

Top of page

Next

 

 

 

 

 

 

What Effects Does it Have on Family and Friends?

The impact on family and other care givers can be very stressful unless during the third stage of the disease the victim can be placed in a care facility such as a convalescent home.  It may still be a burden financially but can give the family some rest and peace of mind about the security and well being of their loved one.  Sometimes there are conflicts between family members as to whether or not to place the loved one in a convalescent home which in many cases only causes hard feelings and severed relationships within a family unit.

In the February 15th issue of the San Diego Union-Tribune there was an article about a day care for Alzheimer's patients which is offered in San Marcos.  The facility has two main purposes: 

bullet

One is that it give the Alzheimer's patients an opportunity to get out of the home and into a different social environment.  

bullet

Two, it gives the families or other dare givers a respite from their daily duties.  The center is open from 7a.m. to 5:30p.m. Monday through Friday.  They offer a host of activities including music, arts and crafts, word and board games and some outdoor games and exercises.

One of our past presidents, Ronald Reagan who had survived bullets and cancer, was diagnosed as having Alzheimer's disease at the age of 82 which may be one of the toughest foes he will have to face.  Ronald Reagan's successful battles with ill health over the years has been an inspiration to all, even those who disagreed with his politics.  He may not be able to win this battle, but the way he's fighting it with candor and courage could be one of his most important legacies, (TIME Domestic/"The Sunset of my Life").

Top of page

Next

 

 

 

 

Conclusion

After researching the subject of Alzheimer's, I now feel that there may be hope for the elderly.  If the proper research is done and we can find a way to genetically change the onset of the disease we may live longer and have a healthier outlook on life for many generations to come.

The stress factor of having to make heartbreaking decisions about our loved ones lifestyle and habitats will be greatly reduced due to their ability to further care for themselves.  This does not mean that we should forget about them.  On the contrary, we should make them a significant part of our lives, visiting with them at every opportunity for they can enrich our minds with the history that they had lived through.

My fathers' mother was afflicted with Alzheimer's disease and was in the third phase  of the disease for about 8 years.  My father visited her every day and tried to comfort her by holding her hand and talking about anything that came to his mind.  She didn't seem to remember him from day to day but from what I have read they can understand a great deal of what we are saying to then even though they cannot communicate in return.  My grandmother spoke an entirely different language (gibberish) but many times her eyes revealed how much pain she was in.  But on the bright side, quoting my father-in-law, "Look at it in a more positive light.   You're meeting new people every day!"

Top of page

Next

 

 

 

 

 

 

References

 

The U.S. Alzheimer's Disease Collaborative Group, London (Reuter) (via the Internet)

The Journal op the American Medical Association (Feb. 21, 1996)

The American Medical Association (Random House, Ó1987 & 1989)

American Biogenetic Sciences, Inc. (Trinity College (Dublin, Ireland) (via the Internet))

Brigham and Women's Hospital, Harvard Medical School (via the Internet)

TIME Domestic / "The Sunset of my Life" (Nov. 14, 1994, vol. 144, No. 20)

San Diego Union-Tribune (Feb. 15th issue)

San Diego Union-Tribune (Feb. 21, 1996)

Funk & Wagnall Corporation (Ó1994)

Top of page

Next

 

 

 

 

 

 

BOOKS!

For additional reading.

bullet

The Molecular Biology of Alzheimer's Disease

bullet

Amyloid Protein Precursor in Development, aging and Alzheimer's Disease

bullet

Image and Brain.  The Resolution of the Imagery Debate, S.M. Kosslyn (The MIT Press, 1994, 516p.) 

bullet

Dementia and Normal Aging, F.A. Huppert, C. Brayne & W. O'Connor, eds. (Cambridge University Press, New York, 1994, 573p.)

bullet

Cognitive Effects of Early Brain Injury, C. Dorman & B. Katzir (Johns Hopkins University Press, Baltimore, 1994, 325p.)

bullet

Pharmacology of Aging Processes (Methods of Assessment and Potential Interventions), I.Zs.-Nagy, D. Harman & K. Kitani, eds. (New York Academy of Sciences, New York, 1994, 350p.)

bullet

Genes and Aging, M.S. Kanungo (Cambridge University Press, Cambridge, 1994, 322p.)

bullet

Functional Neural Transplantation, Stephen B. Dunnett & Anders Bjorklund, eds. (Raven, New York, 1994, 339p.)

bullet

Cellular and Molecular Mechanisms Underlying Higher Neural Functions, A.I. Selverston & P. Ascher, eds. (Wiley, New York, 1994, 328p.)

bullet

Classification & Diagnosis of Alzheimer's Disease: an international perspective.  T. Hovaguimian. (Hogrefe & Huber Pus., P.O. Box 51, Lewiston, NY 14092 USA)

Top of page

 

 

  

  Essays       Creative Writing       Favorite Webs       Recipes       Photo Gallery   

Pandora's Home

Click the e-mail symbol to send mail.

 

Revised  November 02, 2001 
by Sheila Ortman,  sortman@email.com
 

for CIS 212,
Cuyamaca College

 

 

Hit Counter